Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Operating Expenses (2023 - 2026)

Camp4 Therapeutics' Operating Expenses history spans 3 years, with the latest figure at $13.1 million for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 10.64% to $13.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $56.1 million, a 4.31% increase, with the full-year FY2025 number at $56.1 million, up 4.3% from a year prior.
  • Operating Expenses hit $13.1 million in Q4 2025 for Camp4 Therapeutics, down from $14.4 million in the prior quarter.
  • Over the last five years, Operating Expenses for CAMP hit a ceiling of $14.7 million in Q4 2024 and a floor of $12.7 million in Q2 2024.
  • Historically, Operating Expenses has averaged $13.6 million across 3 years, with a median of $13.5 million in 2023.
  • The widest YoY moves for Operating Expenses: up 14.71% in 2025, down 10.64% in 2025.
  • Tracing CAMP's Operating Expenses over 3 years: stood at $13.5 million in 2023, then increased by 8.98% to $14.7 million in 2024, then dropped by 10.64% to $13.1 million in 2025.
  • Business Quant data shows Operating Expenses for CAMP at $13.1 million in Q4 2025, $14.4 million in Q3 2025, and $14.5 million in Q2 2025.